BioCentury
ARTICLE | Company News

EnzymeRx, 3SBio deal

December 6, 2010 8:00 AM UTC

3SBio received exclusive, ex-Taiwanese rights to EnzymeRx's pegsiticase. EnzymeRx, which has ex-Taiwanese rights to the compound from Polaris Pharmaceuticals Inc. (San Diego, Calif.) under a 2008 dea...